Zika update : Clinical laboratory testing and care of infants with congenital Zika virus infection
Published Date:August 23, 2016
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Clinician Outreach and Communication Activity. ; National Center for Immunization and Respiratory Diseases (U.S.) ;
Description:Clinician Outreach and Communication Activity (COCA) webinar, Tuesday, August 23, 2016.
Zika virus infection during pregnancy is a cause of microcephaly and other severe fetal brain defects; however, the full spectrum of infant outcomes is not yet known. CDC has updated its interim guidance for U.S. healthcare providers caring for infants born to mothers with possible Zika virus infection during pregnancy. During this COCA Call, clinicians will learn about these updated interim clinical guidelines, which include evaluation and management recommendations. This information can help pediatric healthcare providers better understand the appropriate tests and clinical approaches for evaluating and managing infants, born to mothers in the United States and its territories, with laboratory evidence of Zika virus infection.
• Interpret revised testing guidance for newborns with possible congenital Zika virus infection.
• Discuss clinical evaluation of infants born to mothers with laboratory evidence of Zika virus infection.
• Outline outpatient management of infants with laboratory evidence of congenital Zika virus infection with and without abnormalities consistent with congenital Zika syndrome.
Supporting Files:No Additional Files
You May Also Like: